NCT01183754

Use of a Point-of-Care Platelet Function Assay for the Prediction of Atherothrombotic Events

Use of a Point-of-Care Platelet Function Assay to Improve the Prediction of Atherothrombotic Events After Implantation of Drug-Eluting Stents: ASAN-VerifyNow Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (actual)
• Sponsor: CardioVascular Research Foundation, Korea · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

1. To evaluate the role of VerifyNow test as prognostic marker in routine clinical practice using drug-eluting stents. 2. To determine the add-on-effect of VerifyNow test beyond on conventional risk factors (clinical, lesions, or procedural factors). 3. To compare the prognostic utility of VerifyNow test with several biomarkers.

Detailed description

Predictive role of a point-of-care assay (VerifyNow test) has not been well evaluated in large number of patients receiving drug-eluting stents as a routine practice. In addition, additional predictive effect of a point-of-care assay, as compared to conventional clinical factors or other biomarkers, might be clinically interesting and important.

Conditions

• Coronary Artery Disease

Timeline

• Start date: 2006-03-01
• Primary completion: 2010-12-01
• Completion: 2010-12-01
• First posted: 2010-08-18
• Last updated: 2011-02-01

Locations

1 site across 1 country: South Korea